Overview

CANHelp Working Group Treatment Trials

Status:
Completed
Trial end date:
2019-05-01
Target enrollment:
Participant gender:
Summary
The CANHelp Working Group Treatment Trials are part of a comprehensive research program carried out by the Canadian North Helicobacter pylori (CANHelp) Working Group. The treatment component involves a series of community-specific trials designed with community input and varying on the specific treatment regimens and number of treatment arms among other study details.
Phase:
Phase 4
Details
Lead Sponsor:
University of Alberta
Collaborators:
Alberta Innovates Health Solutions
ArcticNet
Canadian Institutes of Health Research (CIHR)
Treatments:
Amoxicillin
Bismuth
Bismuth subsalicylate
Clarithromycin
Metronidazole
Rabeprazole
Tetracycline